Media

BIO Investor Forum to be held October 7-8, 2014 in San Francisco, California
Survey responses will help inform Prescription Drug User Fee Act VI negotiations

Press Releases

Feb 24 1999
NEW YORK, N.Y., (February 24, 1999) -- Twenty-one new biotechnology drugs, vaccines and new indications for existing drugs were approved by the Food and Drug...
Feb 19 1999
  Libby Mikesell, Director of Communications at the Biotechnology Industry Organization (BIO), issued the following statement in response to reports...
Feb 11 1999
  Carl B. Feldbaum, president of the Biotechnology Industry Organization (BIO), issued the following statement on the legislation introduced Wednesday...
Feb 8 1999
WASHINGTON, D.C. (Feb. 8, 1999) Among the investor sessions featured at the Biotechnology Industry Organization's (BIO) annual CEO & Investor...
Jan 19 1999
WASHINGTON, D.C. (Jan. 19, 1999) Fifty-two companies will participate in the annual CEO & Investor Conference organized by the Biotechnology Industry...
Jan 15 1999
BIO has long been concerned about the possible misuse of genetic or medical information. Recent news reports about plans to collect data on the health...
Jan 15 1999
The Biotechnology Industry Organization issued the following statement from its Executive Director, Technical Affairs, Alan Goldhammer, Ph.D.: "Health...
Nov 12 1998
(WASHINGTON, D.C., November 12, 1998). . . Carl B Feldbaum, president of the Biotechnology Industry Organization (BIO), today issued the following statement...
Nov 11 1998
(WASHINGTON, D.C., November 11, 1998). . . The Biotechnology Industry Organization (BIO) will host a CEO & Investor Conference in New York Feb. 24-26,...